CIDRAP newsletters options
VRBPAC experts approved the booster recommendation by a 17-to-2 vote.
A new study from researchers at Boston University (BU) shows that, for all but 17% of healthy, vaccinated young adults, the infectious period for COVID-19 from the Delta and Omicron variants was 5 days. The study was recently published in Clinical Infectious Diseases.
The incidence dropped by one-fifth for both mRNA vaccines when dose spacing was longer.
The WHO says it has received reports of 920 probable cases from 33 countries.
As cases top 4,000 worldwide, WHO consultants take a wait-and-see approach.
The Journal of Infectious Diseases has published studies demonstrating lower COVID-19 incidence—but a higher risk of severe disease—in people with Down syndrome (DS), and a lower COVID vaccine immune response.
Emergent BioSolutions said in a news release late last week that the US Food and Drug Administration (FDA) has accepted for review an adjuvanted version of its anthrax vaccine for post-exposure prophylaxis (prevention) of anthrax.
The number of genetic substitutions is 6 times higher than expected for an orthopoxvirus.
An additional 600,000 lives might have been saved if global vaccination goals had been met.
A study yesterday in JAMA Internal Medicine shows that a fourth Pfizer COVID-19 vaccine dose provided 64% to 67% protection against hospitalization and 72% protection against death in nursing home residents, but only 34% protection against infection during an Omicron-dominated period.
A study of adults discharged from more than 900 US hospitals in 2019 found that more than one-third received empiric gram-negative antibiotic therapy, with more than 1 in 5 receiving broad-spectrum antibiotics, researchers reported yesterday in Clinical Infectious Diseases.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
The absolute risk appears to be only slightly higher than in uninfected peers.
Also, global experts meet to consider if the threat constitutes a global public health emergency.
Typhoid fever has become increasingly resistant to antibiotics over the past 50 years.
Maternal COVID vaccination during pregnancy provides 52% protection against COVID-19 hospitalization in infants but only 38% protection against Omicron hospitalization, according to a study yesterday in the New England Journal of Medicine.
Protection against an intensive care unit (ICU) stay, however, was 70%.
A study of Veterans Affairs (VA) patients found that the expectation of an antibiotic had a bigger impact on patient satisfaction than did receipt of an antibiotic, researchers reported today in Antimicrobial Stewardship & Healthcare Epidemiology.
The vaccine produces a strong immune response against the BA.4 and BA.5 Omicron subvariants.
Only 0.74% of patients visited an emergency department and only 0.11% a hospital.
The US Centers for Disease Control and Prevention (CDC) yesterday reported 29 more monkeypox cases, raising the nation's total to 142.
So far 24 states and the District of Columbia have reported cases, up from 21 in the CDC's last update. The most affected states include California, New York, Illinois, and Florida.
